www.statnews.com Open in urlscan Pro
2606:4700::6812:1b65  Public Scan

Form analysis
3 forms found in the DOM

GET https://www.statnews.com/

<form class="header-search search-form" role="search" method="get" action="https://www.statnews.com/">
  <input type="search" class="search-form-field" placeholder="Search …" value="" name="s" aria-label="Search …">
  <button type="submit" class="header-btn header-btn-search">Search</button>
  <button class="header-btn header-btn-back">Cancel</button>
</form>

POST

<form id="coral-display-name-form" class="coral-display-name-form stat-form" method="post">
  <input type="text" id="enter-display-name-input" name="display" placeholder="Create a display name" value="">
  <p id="enter-display-name-error" style="display: none">There was an error saving your display name. Please check and try again.</p>
  <input type="submit" value="Continue">
</form>

POST

<form id="mc4wp-form-1" class="mc4wp-form mc4wp-form-447440 mc4wp-ajax stat-form" method="post" data-id="447440" data-name="Email pop-up — RO">
  <div class="mc4wp-form-fields">
    <div class="stat-form-full">
      <div class="stat-form-brand">
        <img src="https://www.statnews.com/wp-content/uploads/2019/08/Newsletter-Logo-Images_RO.png" alt="The Readout" class="stat-form-brand-logo">
        <p class="stat-form-brand-description">Get the biggest news in biotech delivered straight to your inbox every morning.</p>
      </div>
      <input type="email" name="EMAIL" required="" placeholder="Email Address">
      <div class="stat-form-select-wrapper">
        <select name="ORG" class="has-faux-placeholder is-empty" aria-label="Industry">
          <option value="" selected="">Industry</option>
          <option value="Academia">Academia</option>
          <option value="Advertising/Communications Agency">Advertising/Communications Agency</option>
          <option value="Advocacy/Non-Profit">Advocacy/Non-Profit</option>
          <option value="Banking">Banking</option>
          <option value="Biotech">Biotech</option>
          <option value="Clinical Research Organization">Clinical Research Organization</option>
          <option value="Consulting Firm">Consulting Firm</option>
          <option value="Consumer Health">Consumer Health</option>
          <option value="Financial Services (Other)">Financial Services (Other)</option>
          <option value="Government">Government</option>
          <option value="Healthcare Payer/Insurance">Healthcare Payer/Insurance</option>
          <option value="Health Tech">Health Tech</option>
          <option value="Hospital Systems/Provider">Hospital Systems/Provider</option>
          <option value="Law">Law</option>
          <option value="Media">Media</option>
          <option value="Medical Devices">Medical Devices</option>
          <option value="Medical Technology">Medical Technology</option>
          <option value="Pharmaceuticals">Pharmaceuticals</option>
          <option value="Pharmacy/Retail">Pharmacy/Retail</option>
          <option value="Real Estate">Real Estate</option>
          <option value="Trade Association">Trade Association</option>
          <option value="Technology">Technology</option>
          <option value="Venture Capital">Venture Capital</option>
        </select>
      </div>
      <input type="submit" class="stat-button-primary" value="Sign up for our newsletter">
      <span class="privacy-link"><a href="/privacy/" target="_blank" rel="noopener noreferrer">Privacy Policy</a></span>
      <input type="hidden" name="SRC1" value="bc_modal">
      <input type="hidden" name="CAMPAIGN" value="">
      <input type="hidden" name="INTERESTS[52199cfa15]" value="3baa19d1a4"><!-- RO -->
    </div>
  </div><label style="display: none !important;">Leave this field empty if you're human: <input type="text" name="_mc4wp_honeypot" value="" tabindex="-1" autocomplete="off"></label><input type="hidden" name="_mc4wp_timestamp"
    value="1648757117"><input type="hidden" name="_mc4wp_form_id" value="447440"><input type="hidden" name="_mc4wp_form_element_id" value="mc4wp-form-1">
  <div class="mc4wp-response"></div>
</form>

Text Content

Skip to Main Content
 * 
 * 
 * 
 * Community

Try STAT+ TODAY

 * Contribute
 * Log In
 * Try STAT+ TODAY

My Account
 * My Account
 * Billing
 * Log In

Try STAT+ TODAY My Account
Search Cancel
 * TOPICS
   * Coronavirus
   * Health
   * Pharma
   * Biotech
   * Politics & Policy
   * Health Tech
   * In the Lab
   * Business
   * Artificial Intelligence
   * Vaccines
   * Health Disparities
   * Prescription Politics
 * OPINION
   * First Opinion
   * The Pharmalot View
   * Adam's Take
   * Matt's Take
   * Off the Charts
 * TEAM
   
   * Biotech & Pharma
     
     * Adam Feuerstein
     * Damian Garde
     * Matthew Herper
     * Meghana Keshavan
     * Kate Sheridan
     * Ed Silverman
     * Jonathan Wosen
   
   * Health Tech
     
     * Mario Aguilar
     * Katie Palmer
     * Mohana Ravindranath
     * Casey Ross
   
   * Business & Policy
     
     * Rachel Cohrs
     * Lev Facher
     * Nicholas Florko
     * Bob Herman
   
   * Health & Science
     
     * Eric Boodman
     * Helen Branswell
     * Angus Chen
     * Elizabeth Cooney
     * Isabella Cueto
     * Theresa Gaffney
     * Olivia Goldhill
     * Andrew Joseph
     * Megan Molteni
     * Usha Lee McFarling
     * Jennifer Adaeze Okwerekwu
     * Nicholas St. Fleur
   
   * Team
     
     * View All
 * EVENTS
   * Upcoming Industry Events
   * STAT Events
   * STAT Summits
   * 2022 STAT Breakthrough Science Summit
 * PODCASTS
   * Color Code
   * First Opinion Podcast
   * The Readout LOUD
 * NEWSLETTERS
 * RESOURCES
   * STAT Trials Pulse
   * Reports
   * E-books
 * VIDEO
 * 
 * STAT+
   
   * Exclusive analysis of biotech, pharma, and the life sciences
     
     Learn More
     * The Latest
     * My Account
   
   * Topics
     
     * Biotech
     * Pharma
     * Policy
     * Health Tech
     * Business
   
   * Columns
     
     * Adam's Take
     * Matt's Take
     * The Pharmalot View
   
   * Tools
     
     * CRISPR Trackr
     * Drug Pricing Policy Cheat Sheet
   
   * Events
     
     * STAT+ Conversations
     * All STAT Events
   
   * Team
     
     * Biotech and Pharma
     * Health Tech
     * Politics and Policy
     * Health and Science

Account

 * My Account
 * Billing
 * Subscribe
 * Log In
 * Help

More

 * Community
 * Contribute
 * Group Subscriptions

Follow Us

 * 
 * 
 * 
 * 
 * 

Trending:
Coronavirus
Pharmalot
First Opinion
Biotech

Subscribe Now To access exclusive content, subscribe to STAT+
View Latest View the latest STAT+ stories

In-depth analysis of biotech, pharma, and the life sciences

 * AWARD-WINNING JOURNALISM
   
   from some of the nation's most trusted and well-connected reporters in the
   industry

 * WEEKLY LIVE VIDEO CHATS
   
   with STAT+ reporters and leading industry experts in our STAT+ Conversations
   series

 * EXCLUSIVE INDUSTRY EVENTS
   
   hosted by STAT+, plus early-bird access and discounts to industry events
   around the country

 * DAILY STAT+ NEWSLETTERS
   
   get delivered to your inbox to brief you on the most important industry news
   of the day

 * PREMIUM DATA TOOLS
   
   like our CRISPR Trackr and Drug Pricing Policy Tracker


EXCLUSIVE COVERAGE AND ANALYSIS OF BIOTECH, PHARMA, AND THE LIFE SCIENCES

Try STAT+ 30 days FREE Learn More

In-depth analysis of biotech, pharma, and the life sciences

 * AWARD-WINNING JOURNALISM
   
   from some of the nation's most trusted and well-connected reporters in the
   industry

 * WEEKLY LIVE VIDEO CHATS
   
   with STAT+ reporters and leading industry experts in our STAT+ Conversations
   series

 * EXCLUSIVE INDUSTRY EVENTS
   
   hosted by STAT+, plus early-bird access and discounts to industry events
   around the country

 * DAILY STAT+ NEWSLETTERS
   
   get delivered to your inbox to brief you on the most important industry news
   of the day

 * PREMIUM DATA TOOLS
   
   like our CRISPR Trackr and Drug Pricing Policy Tracker


EXCLUSIVE COVERAGE AND ANALYSIS OF BIOTECH, PHARMA, AND THE LIFE SCIENCES

Try STAT+ 30 days FREE Learn More
Biotech


VERTEX’S NON-OPIOID PAINKILLER MEETS GOALS IN MID-STAGE STUDIES

 * 

By Damian Garde March 31, 2022

Reprints
 * + Comments
 * 
 * 
 * 
 * 
 * 
 * 
 * 
 * 

Bill Sikes/AP
 * 0 Comments
 * 
 * 
 * 
 * 
 * 
 * 
 * 
 * 

A novel pain drug from Vertex Pharmaceuticals met its goals in two mid-stage
trials, the company said Thursday, paving the way for pivotal trials that could
lead to approval.

The highest dose of the drug, a pill called VX-548, beat placebo at reducing
patients’ pain within 48 hours of surgery, Vertex said. The company tested its
medicine in two studies, enrolling about 550 patients who had just undergone
either abdominoplasty or bunionectomy, giving them either placebo, the opioid
treatment hydrocodone, or one of three dosage strengths of VX-548.

Unlock this article — plus daily coverage and analysis of the biotech sector —
by subscribing to STAT+. First 30 days free.

GET STARTED
Log In
 * 0 Comments
 * 
 * 
 * 
 * 
 * 
 * 
 * 
 * 


ABOUT THE AUTHOR REPRINTS


DAMIAN GARDE

National Biotech Reporter

Damian covers biotech, is a co-writer of The Readout newsletter, and a co-host
of "The Readout LOUD" podcast.


damian.garde@statnews.com

@damiangarde


TAGS

biotechnology

pain

STAT+


Add a Comment


CREATE A DISPLAY NAME TO COMMENT

This name will appear with your comment

There was an error saving your display name. Please check and try again.




EXCLUSIVE BIOPHARMA, HEALTH POLICY, AND LIFE SCIENCE ANALYSIS. START YOUR 30-DAY
FREE TRIAL TODAY.

TRY STAT+


CATCH UP ON THE LATEST MUST-READ COVERAGE AND ANALYSIS

Read Now

advertisement




POPULAR

 * 
   ‘Where the bats hung out’: How a basement hideaway at UC Berkeley nurtured a
   generation of blind innovators
 * 
   In the wake of big patent decision, it’s business as usual for CRISPR therapy
   developers
 * 
   Califf admits controversy over FDA’s Alzheimer’s drug decision impacted
   experts’ trust in the agency
 * 
   U.S. approves second Covid-19 booster for people 50 and older
 * 
   Obesity can turn a helpful immunotherapy into a harmful one, mouse study
   shows

advertisement



Trending
Biden’s high-stakes biomedical science agency ARPA-H will be part…
Biden’s high-stakes biomedical science agency ARPA-H will be part of the NIH —
but there’s a…

U.S. approves second Covid-19 booster for people 50 and…
U.S. approves second Covid-19 booster for people 50 and older

Why fentanyl is deadlier than heroin, in a single…
Why fentanyl is deadlier than heroin, in a single photo
Recommended
In the wake of big patent decision, it’s business…
In the wake of big patent decision, it’s business as usual for CRISPR therapy
developers

Biden’s high-stakes biomedical science agency ARPA-H will be part…
Biden’s high-stakes biomedical science agency ARPA-H will be part of the NIH —
but there’s a…

Pharmalittle: Advisory panel narrowly votes down ALS drug; Vertex…
Pharmalittle: Advisory panel narrowly votes down ALS drug; Vertex looks to
advance experimental pain drug


RECOMMENDED STORIES

Pharma


ROCHE ANTI-TIGIT CANCER IMMUNOTHERAPY FAILS IN FIRST LATE-STAGE CLINICAL TRIAL

By Adam Feuerstein

Biotech


TRACKING THE FDA ADVISORY PANEL ON AMYLYX PHARMA’S ALS TREATMENT

By Adam Feuerstein and Nicholas Florko

advertisement


Health


SHE WAS TOLD ‘GIRLS DON’T DO THAT.’ NOW MARGARET-MARY WILSON IS A TOP EXECUTIVE
AT UNITEDHEALTH GROUP

By Usha Lee McFarling

Health Tech


HUMILITY OVER HYPE: AN AI LEADER AT GOOGLE LAYS OUT A VISION TO TRANSFORM
MEDICAL CARE

By Casey Ross

A STAT Investigation


HOW AMERICA’S LARGEST CATHOLIC HOSPITAL SYSTEM IS MOONLIGHTING AS A PRIVATE
EQUITY FIRM

By Rachel Cohrs

Get the biggest news in biotech delivered straight to your inbox every morning.

Industry Academia Advertising/Communications Agency Advocacy/Non-Profit Banking
Biotech Clinical Research Organization Consulting Firm Consumer Health Financial
Services (Other) Government Healthcare Payer/Insurance Health Tech Hospital
Systems/Provider Law Media Medical Devices Medical Technology Pharmaceuticals
Pharmacy/Retail Real Estate Trade Association Technology Venture Capital
Privacy Policy
Leave this field empty if you're human:


Reporting from the frontiers of health and medicine

Trending:
 * Coronavirus
 * Pharmalot
 * First Opinion
 * Biotech
 * Health
 * Health Tech

Back to top


COMPANY

 * About STAT
 * Awards
 * Contact Us
 * Careers & Internships
 * Contribute
 * Diversity & Inclusion
 * Licensing Stories
 * Our Team


ACCOUNT

 * About STAT+
 * FAQs
 * Log In
 * Subscribe


APP & OTHER PRODUCTS

 * STAT App
 * Newsletters
 * Podcasts
 * STAT Madness
 * STAT Reports
 * STAT Trials Pulse
 * STAT Wunderkinds


GROUP SUBSCRIPTIONS

 * Contact Us
 * Request A Quote


ADVERTISING

 * Advertise With Us
 * Download Media Kit


EVENTS

 * Upcoming Industry Events
 * STAT Events
 * STAT Summits
 * Sponsor An Event

 * Privacy
 * Comment Policy
 * Terms
 * Do Not Sell my Data
 * ©2022 STAT

 * 
 * 
 * 
 * 
 * 

 


Please review our cookie policy

We use first- and third-party cookies to customize your experience and display
advertising. By continuing to use the site, you agree to our use of cookies. If
you want to know more or opt out in whole or in part, please see our Privacy
Notice and our Cookie FAQ.

Accept No thanks